Advance your examination of cannabis with Restek’s new Cannabidivarinic Acid norm Kumar Jeetendra | June 22, 2020 Cannabidivarinic Acid (CBDVA) is a non-psychoactive cannabinoid answered to have mitigating properties. While its therapeutic advantages are as yet being explored, evaluating this compound in cannabis tests is significant for getting a genuine estimation of strength and chemovar distinguishing proof. Restek now offers another CBDVA confirmed reference material (CRM) to assist labs with propelling their …
CBD could lessen lung harm brought about by COVID-19 Kumar Jeetendra | October 19, 2020 One way CBD appears to reduce the”cytokine storm” that damages the lungs and kills many individuals with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is proven to reduce inflammation and whose levels are dramatically reduced in the face of this storm. Dental College of Georgia and Medical …
Altered lipids focus on the body’s endocannabinoid framework to control pain and inflammation Kumar Jeetendra | February 10, 2021 When modified using a process known as epoxidation, two naturally occurring lipids are converted to potent agents that target multiple cannabinoid receptors in neurons, interrupting pathways which promote inflammation and pain, researchers report. These modified compounds, called epo-NA5HT and epo-NADA, have much stronger effects than the molecules from which they are derived, which also modulate …
Study reveals insight into the capacity of CBD to decrease pain Kumar Jeetendra | April 24, 2021 It’s been hailed as a wonder drug and it’s certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024. While consumers tout its effectiveness in pain relief, up until now there has been limited experimental human research on the true effectiveness of the medication. But …
